Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Our Process Start Your Path to Better Health Taking control of your health is simple and supportive
Nearly 8% of all prescriptions in March 2026 were for GLP-1 RAs, following the largest quarter-over-quarter percentage point increase in overall GLP-1 RA prescribing observed since the study began in 2019
Important safety considerations : These medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
GLP-1 weight loss patients typically lose 30 to 80 pounds and often present with mild to moderate skin laxity, while bariatric surgery patients commonly lose 80 to 150-plus pounds with more severe excess skin
Wu H, Diao J, Li X, Yue D, He G, Jiang X, et al
US$ 29.34
US$ 28.43
US$ 29.64
US$ 21.29
US$ 22.27
